Supriya Lifescience Ltd; has forced its research and regulatory activities on developing new formulations and complex generic products. Supriya has 5 ANDA under development.
Our scientists are currently developing dosage form products including analgesics, anesthetics, anti-depressants, and anti-obesity. Our formulation R&D is equipped with state-of-the-art equipment for tablets, capsules, and injectable development.